NYSE: AGX · Engineering & Construction

Argan (AGX) fair value: undervalued or overvalued?

As of 14 Nov 2026, Faircurve's model values Argan (AGX) at $290.96 a share. The stock last closed at $294.36, which puts the model's fair value 1.2% below the price. On the model's bands that reads as Fairly valued.

Revalued . Price is the close of 16 Nov 2026. Argan, Inc.

The report adds the live price, the chart against the range the options market prices, the next earnings date and the analysts' consensus. No account needed.

Model fair value$290.96midpoint of 2,000 simulations
Last close$294.36NYSE: AGX
Gap to fair value-1.2%fair value against price
Model verdictFairly valuedevidence grade: Medium

This week, in three parts

What happenedThe run of 14 Nov 2026 moved the fair value from $269.00 to $290.96 (+8.2%). The stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move.

What the model makes of itThe price of $294.36 is 1.2% above it: Fairly valued, on a medium evidence grade.

What's nextReports on 3 Dec 2026. Options expiring after the report price a move of about 21% either way. The next weekly run is on Saturday 21 Nov 2026.

What price range does the model give AGX?

The calibrated range for AGX over 63 trading days is $219.80 to $400.06. It sits around the last close, and its width comes from the volatility that AGX's own options imply (89% a year), calibrated weekly against realised prices (n = 8,038 past valuations, refreshed 14 Nov 2026). Ranges built this way held the price 60% of the time at this horizon. The fair value is the model's opinion and rides beside the range. It is not the centre of it.

The model's own simulated range, from the 20th to the 80th percentile of its runs, is $211.34 to $399.32. In 45% of the simulations the fair value came out above the price the model ran on.

$145.78$637.65
Spread of the 2,000 simulated fair values. Solid line: the midpoint, $290.96. Dashed line: the last close, $294.36.

Faircurve Insights · 14 Nov 2026

Argan, Inc. (AGX) is an Industrials company in Engineering & Construction. Operating through its various subsidiaries, it offers a comprehensive suite of services to the power generation and renewable energy sectors.

On 14 Nov 2026, Faircurve's model set the fair value at $290.96 a share. The previous run, on 7 Nov 2026, gave $269.00, a move of +8.2%. The model's reason, in its own words, is that the stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move. The calibrated range over 63 trading days is $232.10 to $410.41. Ranges built this way have held the stock's price 60% of the time at this horizon. The evidence grade is Medium. It reflects input completeness, the number and agreement of comparable companies, and the spread of outcomes. It does not say whether the fair value is right.

The business scores 76 out of 100 on quality, a composite of six factors measured against comparable companies. Profitability and the balance sheet each score 100: ROIC is 106.6% against a peer median of 10.5%, and net debt to EBITDA is -1.67x against a peer median of 1.83x. Stability scores 13, with five-year EBITDA margin downside volatility of 1.7 pts against a peer median of 0.7 pts. The model compares it with MYR Group Inc. (MYRG), Everus Construction Group, Inc. (ECG), Exponent, Inc. (EXPO), Primoris Services Corporation (PRIM), Granite Construction Incorporated (GVA), Fluor Corporation (FLR) and Dycom Industries, Inc. (DY).

Written from the figures on this page for the 14 Nov 2026 valuation and checked by rule before publishing: every number is one printed here, no forecast, no instruction. The price, the gap and the verdict are the page's own and change daily. Not a recommendation.

The Global Pulse

Faircurve's note after each US session, in your inbox. No account needed.

When does AGX report earnings, and how has the stock reacted?

Argan's next earnings report is scheduled for 3 Dec 2026. Companies can move their dates.

Options prices on 16 Nov 2026 imply a move of about 20.6% in either direction through the nearest expiry, about 31 days out, a window that includes the report. That is the size the market is pricing, not a direction. AGX's 30 day implied volatility works out to about 25.6% over one month.

Around its last 8 reports: what the options market priced, and what followed

Each move runs from the last close before the report to the first close after it, so it covers companies that report before the open and after the close. The median size across AGX's last 8 reports, ignoring direction, was 8.7%.

0%10%20%30%no quote25.7%5 Sep '2414.9%1.2%5 Dec '2415.4%15.6%27 Mar '2515.6%6.8%4 Sep '2515.2%10.6%4 Dec '2519.8%29.5%26 Mar '2618.0%1.2%4 Jun '2617.8%1.7%2 Sep '26priced before the reportthe move that followed
What the options market priced for each report, against the size of the move that followed. Priced: the move implied by options expiring after the report, on the last quote before it. Followed: the close before the report to the close after. Sizes only, no direction.

What the options market has priced for a month's move in AGX

15%20%25%30%35%2 Sep '26 report4 Jun '26 report26 Mar '26 report4 Dec '25 report26% at 16 Nov '2614 Nov '2516 Nov '26
What the options market priced for a month's move (30-day implied volatility, scaled to one month). It read 25% on 14 Nov 2025, reached 29% on 28 Aug 2026 and reads 26% on 16 Nov 2026. The marks are report dates.

How does AGX score on business quality?

Argan's overall quality score is 76 out of 100. Each factor below is a score against comparable companies, not a percentile of the metric beside it.

FactorScore (0 to 100)Headline measurePeer median
ProfitabilityReturn on invested capital against the peer group, with a bonus for an improving trend.100106.6%ROIC10.5%
Earnings qualityHow much of reported profit is cash: free cash flow to net income, and the accrual ratio (the share of earnings that is not cash).913.04xFCF / net income1.51x
Growth qualityTrailing revenue growth, forward growth from consensus, and the direction of analysts' rating changes.458.1%Revenue growth, trailing20.3%
Capital disciplineReinvestment efficiency (capital spending per unit of revenue) and net buybacks.750.3%Net buybacks / market value0.2%
Balance sheetNet debt to EBITDA and interest coverage.100-1.67xNet debt / EBITDA1.83x
StabilityDownside volatility of the EBITDA margin over the last five years.131.7 ptsEBITDA margin downside volatility, 5y0.7 pts

How does AGX compare with similar companies?

The companies in engineering & construction closest to Argan in market value, each on the same model and the same date.

CompanyLast closeModel fair valueGapModel verdict
MYRG MYR Group Inc.$267.85$261.90-2.2%Fairly valued
ECG Everus Construction Group, Inc.$82.92$96.37+16.2%Undervalued
EXPO Exponent, Inc.$88.18$81.75-7.3%Fairly valued
KBR KBR, Inc.$35.35$40.97+15.9%Low evidence grade
PRIM Primoris Services Corporation$67.14$69.96+4.2%Fairly valued
GVA Granite Construction Incorporated$122.24$137.36+12.4%Fairly valued
FLR Fluor Corporation$48.39$56.17+16.1%Undervalued
DY Dycom Industries, Inc.$215.39$229.88+6.7%Fairly valued

What the comparable companies' multiples alone would give for AGX, the peer-implied price, is $266.08 a share on this run. The fair value weighs that against the company's own multiple.

All engineering & construction stocks ranked by gap to fair value

Argan at a glance

Argan, Inc., operating through its various subsidiaries, offers a comprehensive suite of services to the power generation and renewable energy sectors.

Market value
$4.3B
Sector
Industrials
Industry
Engineering & Construction
Revenue expected, next twelve months
$1.6B
Consensus revenue growth, next fiscal year
+48.3%
Analysts with estimates
4
Beta to the US market
1.83
First valued by Faircurve
11 Jul 2026

At the close of 16 Nov 2026, 56.8% of the 1,085 graded US stocks the model covers traded below the model's fair value. AGX was not among them.

How the fair value is worked out: the model prices Argan on the value of the whole business, debt included, against the operating profit analysts expect next year (forward EV/EBITDA), runs 2,000 simulations across its inputs and takes the midpoint. The full method is documented here.

What changed in the latest valuation?

On 7 Nov 2026 the model's fair value for AGX was $269.00. As of 14 Nov 2026 it is $290.96, a change of +8.2%. The stock's own trading multiple rose with its price, and the fair value follows it in part: most of the move. The model revalues every stock it covers each week, and again after an earnings report.

Questions about Argan's valuation

Is Argan stock undervalued or overvalued?

On Faircurve's model, AGX reads as Fairly valued as of 14 Nov 2026. The model's fair value is $290.96 a share against a last close of $294.36, a gap of -1.2%.

What is AGX's fair value?

$290.96 a share as of 14 Nov 2026, the midpoint of 2,000 simulations. The model's own 20th to 80th percentile range is $211.34 to $399.32.

What price range does the model give AGX?

$219.80 to $400.06 over 63 trading days. Ranges built this way held the price 60% of the time across 8,038 past valuations, refreshed 14 Nov 2026.

When does Argan report earnings next?

The next report is scheduled for 3 Dec 2026. Companies can move their dates.

How much has AGX moved on past earnings reports?

Across its last 8 reports the median two session move was 8.7%, ignoring direction. The largest was +29.5% around the report of 26 Mar 2026.

How confident is the model in this valuation?

The model's evidence grade for AGX is medium. The grade looks at how complete the inputs are, how many comparable companies there are and how closely they agree, and how wide the range of outcomes is. It is not a probability that the fair value is right, or that the price reaches it.

The model's own ideas on AGX

The model holds no idea open on AGX today. Signed-in readers see the rule each idea runs on, the floor and the exit level the model set and its time limit, and the model's closed ideas on AGX with their outcomes. A free account is enough.

Keep reading